This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2004 Aug;5(3):189-97.

doi: 10.1023/B:REMD.0000032407.88070.0a.

Endothelial dysfunction, inflammation and diabetes

Paresh Dandona¹, Ahmad Aljada, Ajay Chaudhuri, Priya Mohanty

Affiliations

Affiliation

¹ Division of Endocrinology, Diabetes and Metabolism, State University of New York at Buffalo and Kaleida Health, 3 Gates Circle, Buffalo, NY 14209, USA. pdandona@Kaleidahealth.org

PMID: 15211090
DOI: 10.1023/B:REMD.0000032407.88070.0a

Review

Endothelial dysfunction, inflammation and diabetes

Paresh Dandona et al. Rev Endocr Metab Disord. 2004 Aug.

. 2004 Aug;5(3):189-97.

doi: 10.1023/B:REMD.0000032407.88070.0a.

Authors

Paresh Dandona¹, Ahmad Aljada, Ajay Chaudhuri, Priya Mohanty

Affiliation

¹ Division of Endocrinology, Diabetes and Metabolism, State University of New York at Buffalo and Kaleida Health, 3 Gates Circle, Buffalo, NY 14209, USA. pdandona@Kaleidahealth.org

PMID: 15211090
DOI: 10.1023/B:REMD.0000032407.88070.0a

No abstract available

PubMed Disclaimer

Similar articles

Insulin as a first-line therapy in type 2 diabetes: should the use of sulfonylureas be halted?
Standl E, Schnell O. Standl E, et al. Diabetes Care. 2008 Feb;31 Suppl 2:S136-9. doi: 10.2337/dc08-s234. Diabetes Care. 2008. PMID: 18227474 No abstract available.
Role of insulin secretagogues and insulin sensitizing agents in the prevention of cardiovascular disease in patients who have diabetes.
Jawa AA, Fonseca VA. Jawa AA, et al. Cardiol Clin. 2005 May;23(2):119-38. doi: 10.1016/j.ccl.2004.06.001. Cardiol Clin. 2005. PMID: 15694742 Review.
Is there evidence that oral hypoglycemic agents reduce cardiovascular morbidity/mortality? Yes.
Bianchi C, Miccoli R, Daniele G, Penno G, Del Prato S. Bianchi C, et al. Diabetes Care. 2009 Nov;32 Suppl 2(Suppl 2):S342-8. doi: 10.2337/dc09-S336. Diabetes Care. 2009. PMID: 19875578 Free PMC article. Review. No abstract available.
[Anti-diabetic treatment, insulin resistance and cardiovascular disease in patients with type 2 diabetes].
Hemmingsen B, Lund SS, Vaag A. Hemmingsen B, et al. Ugeskr Laeger. 2009 May 4;171(19):1598-602. Ugeskr Laeger. 2009. PMID: 19419642 Review. Danish.
Inflammation in atherosclerosis and diabetes mellitus.
Plutzky J. Plutzky J. Rev Endocr Metab Disord. 2004 Aug;5(3):255-9. doi: 10.1023/B:REMD.0000032414.17672.5c. Rev Endocr Metab Disord. 2004. PMID: 15211097 Review. No abstract available.

See all similar articles

Cited by

The potential role of phytochemicals in wholegrain cereals for the prevention of type-2 diabetes.
Belobrajdic DP, Bird AR. Belobrajdic DP, et al. Nutr J. 2013 May 16;12:62. doi: 10.1186/1475-2891-12-62. Nutr J. 2013. PMID: 23679924 Free PMC article. Review.
Postoperative Insulin Dose for Cardiac Artery Bypass Graft and Other Cardiac Surgeries in Patients with Type 2 Diabetes: A Retrospective Study.
Fukuda Y, Ushigome E, Yamazaki M, Fukui M. Fukuda Y, et al. Vasc Health Risk Manag. 2024 Feb 23;20:59-68. doi: 10.2147/VHRM.S447077. eCollection 2024. Vasc Health Risk Manag. 2024. PMID: 38414907 Free PMC article.
The markers of inflammation and endothelial dysfunction in correlation with glycated haemoglobin are present in type 2 diabetes mellitus patients but not in their relatives.
Gómez JM, Vila R, Catalina P, Soler J, Badimón L, Sahún M. Gómez JM, et al. Glycoconj J. 2008 Aug;25(6):573-9. doi: 10.1007/s10719-008-9118-8. Epub 2008 Mar 18. Glycoconj J. 2008. PMID: 18347976
Burkholderia pseudomallei triggers altered inflammatory profiles in a whole-blood model of type 2 diabetes-melioidosis comorbidity.
Morris J, Williams N, Rush C, Govan B, Sangla K, Norton R, Ketheesan N. Morris J, et al. Infect Immun. 2012 Jun;80(6):2089-99. doi: 10.1128/IAI.00212-12. Epub 2012 Apr 2. Infect Immun. 2012. PMID: 22473609 Free PMC article.
Increased blood flow by insulin infusion targeting normoglycemia in patients with severe sepsis: friend or foe?
Van den Berghe G. Van den Berghe G. Crit Care. 2010;14(1):122. doi: 10.1186/cc8228. Epub 2010 Feb 16. Crit Care. 2010. PMID: 20236504 Free PMC article.

See all "Cited by" articles

References

1. J Clin Endocrinol Metab. 2003 Sep;88(9):4496-501 - PubMed
1. Ann Med. 1999 Jun;31(3):156-65 - PubMed
1. Diabetes Care. 2002 Dec;25(12):2244-8 - PubMed
1. Science. 1993 Jan 1;259(5091):87-91 - PubMed
1. Adv Prostaglandin Thromboxane Leukot Res. 1995;23:263-5 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
Medical
- ClinicalTrials.gov
- MedlinePlus Health Information